Background: cMyBP‐C (Cardiac myosin binding protein‐C) regulates cardiac contraction and relaxation. Previously, we demonstrated that elevated myocardial S‐glutathionylation of cMyBP‐C correlates with diastolic dysfunction (DD) in animal models. In this study, we tested whether circulating S‐glutathionylated cMyBP‐C would be a biomarker for DD. Methods and Results: Humans, African Green monkeys, and mice had DD determined by echocardiography. Blood samples were acquired and analyzed for S‐glutathionylated cMyBP‐C by immunoprecipitation. Circulating S‐glutathionylated cMyBP‐C in human participants with DD (n=24) was elevated (1.46±0.13‐fold, P =0.014) when compared with the non‐DD controls (n=13). Similarly, circulating S‐glutathionylated cMyBP‐C was upregulated by 2.13±0.47‐fold ( P =0.047) in DD monkeys (n=6), and by 1.49 (1.22–2.06)‐fold ( P =0.031) in DD mice (n=5) compared with the respective non‐DD controls. Circulating S‐glutathionylated cMyBP‐C was positively correlated with DD in humans. Conclusions: Circulating S‐glutathionylated cMyBP‐C was elevated in humans, monkeys, and mice with DD. S‐glutathionylated cMyBP‐C may represent a novel biomarker for the presence of DD.
4 February 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
MANTA is an effective vascular closure device (VCD) in patients undergoing transcatheter aortic valve replacement (TAVR); however, the lack of a convenient bailout for device-related vascular complications is a limitation. The objective of this study is to examine the safety and efficacy of ipsilateral safety wire (ISW) as a bailout for MANTA failure in patients undergoing TAVR. Our institutional Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy (STS/ACC TVT) registry and EPIC chart system were queried to identify patients who underwent TAVR with MANTA and ISW from July 1, 2022, to June 30, 2023. The ISW involves ipsilateral arterial access distal to primary access and placement of a 0.018" wire in a retrograde fashion in the descending aorta. The primary safety outcome was the absence of complications related to the ISW technique. The primary efficacy outcome was successful MANTA closure, with or without the utilization of the ISW technique, defined as achieving hemostasis without impairment of distal perfusion or need for surgical vascular intervention. Eighty-nine patients were included (mean age 81.1 years, 32.6% women, 98.9% White). Most procedures were performed electively (95.5%) in a hybrid operating room (83.1%) with conscious sedation (82.0%), using balloon-expandable valves (98.9%). The primary safety and efficacy outcomes were achieved in all patients. Two patients (2.2%) required utilization of the ISW technique for bailout; 1 for inadequate hemostasis, and 1 for severe common femoral artery stenosis. No major bleeding or surgical vascular intervention occurred. The ISW technique is a safe and effective bailout technique for MANTA in patients undergoing TAVR.
7 November 2023 in Journal of the American Heart Association